[1]
2025. Comparative Cardioprotective Effects of SGLT2 Inhibitors in Preclinical Models of Diabetic Cardiomyopathy. Vascular and Endovascular Review. 8, 20s (Dec. 2025), 1–9. DOI:https://doi.org/10.64149/J.Ver.8.20s.1-9.